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Abstract In recent years, the actin cytoskeleton in Schizosac-
charomyces pombe has become the subject of intense scrutiny.
However, to date, only a single actin mutation has been
identified. Described here is the isolation and characterization
of four new cold-sensitive actin mutations. Sequence analysis of
the mutant actin genes indicated that each of these mutations
caused alterations in single amino acids that are conserved in all
actin sequences. These mutants differ in their phenotypes. One of
these mutations (act1-48) was identified as an extragenic
suppressor of a mutation in the cdc4 gene, which is required
for actin ring formation and cytokinesis. Interestingly, when
act1-48 mutant cells were shifted to the restrictive temperature,
actin patches were not detected but the actin ring formation and
stability was unaffected. The three other mutations, act1-16,
act1-32 and act1-67, primarily affected the actin ring formation
or stability while F-actin patches did not seem to be substantially
different in appearance. Given that the ultrastructural architec-
tures of F-actin patches and the F-actin ring are presently
unclear, these mutations, which affect one structure or the other,
should be useful for future studies on the role of actin itself in the
function of these F-actin-containing structures in S. pombe.
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1. Introduction
In eukaryotic cells, the actin cytoskeleton plays a funda-
mental role in numerous cellular processes including cell mo-
tility, cytokinesis, cell polarity and, in yeast, secretion and
endocytosis [1]. The function of actin and its associated pro-
teins in these processes is exceedingly complex. Simple genetic
systems such as yeast have proven to be quite useful in dis-
secting complex cellular pathways. Considerable characteriza-
tion of the actin cytoskeleton in the budding yeast Saccharo-
myces cerevisiae has been achieved. Many actin binding
proteins have been identi¢ed in a large measure due to the
large number of actin mutants available in this organism.
These were created by direct mutagenesis of the S. cerevisiae
actin gene [2,3]. They have been used for a number of di¡erent
genetic screens to identify components that interact with the
actin cytoskeleton [4^6].
Other studies suggest that the ¢ssion yeast Schizosaccharo-
myces pombe may also be a valuable model organism for the
study of actin function [7]. The actin cytoskeleton of S. pombe
contains three major types of F-actin structures which re-or-
ganize during the cell cycle. In the interphase, actin is found in
patches localized at the growing ends of cells. Actin cables
which run the length of the cell have also been observed. At
the onset of mitosis, a ring of F-actin forms in the medial
region of the cells which is believed to be analogous to the
cleavage furrow of higher eukaryotes. During the anaphase,
actin patches become concentrated adjacent to the actin ring
rather than at the cell ends. After completion of the anaphase,
the ring begins to constrict and the septum is deposited in the
wake of the constricting ring. Upon exit from mitosis, actin
patches once again localize to the growing ends of the cell.
Numerous S. pombe mutants have been isolated that a¡ect
cytokinesis (reviewed in [8,9]). Many of the corresponding
genes encode actin binding proteins. Also, numerous cell
shape and growth polarity mutants of S. pombe have identi-
¢ed proteins that modulate the actin cytoskeletal architecture
(reviewed in [10]). However, only a single actin allele has been
identi¢ed in S. pombe [11] and no actin mutations have been
identi¢ed that cause a loss of actin patches. In this paper, we
describe the identi¢cation and characterization of four new
cold-sensitive alleles of the actin gene, each with distinctive
properties. Further study of these mutants should enable the
role of actin in cellular processes to be evaluated and should
provide a means to use genetic analysis to identify actin-in-
teracting proteins.
2. Materials and methods
2.1. Strains, media and genetic and molecular biology methods
S. pombe strains used in this study are listed in Table 1. Growth
media were as previously described [12]. Cells were grown in yeast
extract (YE) medium or EMM minimal medium with appropriate
supplements. Standard genetic and recombinant DNA methods
[12,13] were used except where noted. Yeast transformations were
performed using electroporation [14]. Because the act1-16, act1-32
and act1-67 strains mated poorly, genetic crosses involving these
strains were performed by selecting for diploid cells using nutritional
markers following standard crosses or cell fusion [12]. Diploid strains
were then induced to sporulate by incubation in ME medium. All
double mutant strains were constructed by tetrad dissection using a
Singer MSM dissecting microscope. DNA was prepared from bacteria
and isolated from agarose gels using Qiagen kits and from yeast cells
as previously described [15].
2.2. Genetic screens
The act1-48 strain was isolated in a screen for cdc4-8 suppressors.
Approximately 2U108 cells of a cdc4-8 ura4-D18 leu1-32 h3 strain
were mutagenized for 15 min with nitrosoguanidine (NTG) as de-
scribed [12] and plated at 36‡C. This screen yielded 400 colonies.
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12 of these colonies were unable to grow at 19‡C and were pursued
further. These 12 strains were crossed to wild-type cells (YDM53) to
determine if the suppressing mutation was intragenic or extragenic
and whether the cold-sensitive phenotype was linked to the suppressor
mutation. Four strains were identi¢ed as carrying extragenic cold-
sensitive suppressor mutations and these were characterized further
as described in Section 3. All mutants were then back-crossed at least
three times to wild-type strains YDM53, YDM105, YDM106,
YDM107 or YDM108 as appropriate.
A previously described strategy [16^19] was employed to screen for
cold-sensitive mutants defective in cytokinesis. A mam2 : :LEU2 ade6-
M216 leu1-32 ura13 h90 (JZ758, a kind gift of Dr C. Shimoda) strain
was used as the starting strain for mutagenesis. The homothallic
mam2 null mutant is capable of mating with h3 cells but is incapable
of mating with h cells due to the fact that the mam2 gene encodes
the plus factor receptor. However, a diploid strain of the genotype
mam2 : :LEU2/mam2 : :LEU2 h90/h90 is capable of meiosis and sporu-
lation since conjugation is not necessary under these circumstances.
The genetic screen was carried out with the following rationale. JZ758
was mutagenized with NTG and cells were allowed to recover, after
mutagenesis, at 30‡C until cells began to cycle normally. The culture
was then split three ways and shifted to 19‡C for 8 h. Following the
temperature shift, cells were washed three times with sporulation me-
dium and incubated in the same medium for 3 days to allow meiosis
and sporulation. Spores were prepared by digesting ascus and cell
walls with glusulase and spores were suspended in water. Spores
were plated on YE agar plates and incubated at 30‡C until colonies
appeared. Colonies were replica-plated to YE agar plates containing
the vital dye phloxin B and incubated 2 days at 19‡C. These plates
were screened microscopically for phenotypes exhibited by cytokinesis
mutants. Five mutant strains (act1-41, act1-16, act1-32, act1-67 and
act1-127) were chosen for further analysis and were back-crossed at
least three times to wild-type strains YDM105, YDM106, YDM107
or YDM108 as appropriate.
2.3. Identi¢cation of act1 mutations
Genomic DNA was isolated from S. pombe act1 mutant strains as
described [15]. The act1 encoding region of each strain was ampli¢ed
by the polymerase chain reaction (PCR) using the oligonucleotides 5P-
CCCTCAAAAGACAAGACC-3P and 5P-CGTTACAAAAAGTAA-
GAGGAGC-3P. The resultant DNA fragments were sequenced di-
rectly using the Thermo Sequenase radiolabelled terminator cycle se-
quencing kit (Amersham) and the priming oligonucleotides. To
complete the DNA sequence of each PCR fragment, the oligonucleo-
tide 5P-GTTTTGTCTTTGTATGCC-3P was used to prime the reac-
tions. A single base substitution relative to wild-type act1 was de-
tected in each PCR fragment. Oligonucleotide primers were obtained
from Operon.
2.4. Microscopy
All £uorescence microscopy was performed using a Nikon 600 mi-
croscope and images were captured using a Dage CCD camera. DNA
and septal material were visualized using DAPI and calco£uor, re-
spectively, as described by Balasubramanian et al. (1997). Immuno-
£uorescence was performed using methanol ¢xation as described pre-
viously [20]. Antibodies to Cdc4p [21] and actin (Amersham) were
diluted 1:100 and detected with Texas red-tagged anti-rabbit IgG
and Texas red-tagged anti-mouse IgG antibodies (Molecular Probes).
3. Results
3.1. Identi¢cation of an actin mutant as a suppressor of the
cdc4-8 mutation
In order to identify genes important for the function of
Cdc4p, an EF-hand protein with properties of a myosin light
chain, we screened for mutations capable of suppressing the
cdc4-8 temperature-sensitive growth defect at 36‡C. Strain
KGY439 (cdc4-8 ura4-D18 leu1-32 h3) was mutagenized
with NTG and incubated at 36‡C. Colonies that arose were
replica-plated to 19‡C and assayed for growth. Strains which
were unable to grow at 19‡C were crossed to wild-type cells to
determine if the cdc4-8 suppression was extragenic and segre-
gated with the cold-sensitive phenotype. Four such extragenic
cold-sensitive suppressors were identi¢ed. Each suppressor
strain was back-crossed to wild-type three times to create
strains carrying the suppressor mutation on its own. Linkage
analysis demonstrated that the four suppressor mutations de-
¢ned a single genetic locus. In order to test for dominance,
each suppressor strain was crossed to a mei1-102 strain (mei1-
102 mutants will mate with h3 partners, but the resulting
diploids will not sporulate) and stable diploids were obtained
using complementation of auxotrophic markers. All suppres-
sor mutations were found to be recessive for the cold-sensitive
growth phenotype. To test whether these mutations were
dominant in their ability to suppress the cdc4-8 growth defect
at 36‡C, diploid strains homozygous for the cdc4-8 mutation
but heterozygous for the suppressing mutations were con-
structed. These diploid strains were capable of growth at
36‡C, thus the suppressing mutations are dominant in their




JZ758 mam2: :LEU2, leu1-32 ura1 ade6-M216, h90 C. Shimoda
KGY439 cdc4-8 ura4-D18 leu1-32 h Our stock
YDM105 leu1-32 ura4-D18 ade6-210 h3 Our stock
YDM106 leu1-32 ura4-D18 ade6-210 h Our stock
YDM107 leu1-32 ura4-D18 ade6-216 h3 Our stock
YDM108 leu1-32 ura4-D18 ade6-216 h Our stock
YDM53 lys1-131 h Our stock
YDM189 act1-48 ura4-D18 leu1-32 lys1-131 h3 This study
YDM190 act1-48 ura4-D18 leu1-32 lys1-131 h This study
FCS41 act1-41 mam2: :LEU2, leu1-32 ura1 ade6-M216, h90 This study
FCS127 act1-127 mam2: :LEU2, leu1-32 ura1 ade6-M216, h90 This study
YDM181 act1-16 ura4-D18 leu1-32 ade6-216 h3 This study
YDM184 act1-32 ura4-D18 leu1-32 ade6-210 h3 This study
YDM182 act1-67 ura4-D18 leu1-32 ade6-216 h3 This study
YDM93 cdc4-8 act1-48 ura4-D18 leu1-32 lys1-131 h This study
KGY492 cdc3-124 leu1-32 ura4-D18 ade6-216 h Our stock
KGY901 cdc8-110 leu1-32 ura4-D18 ade6-210 h Our stock
KGY1003 cdc12-112 leu1-32 ura4-D18 ade6-210 h Our stock
YDM28 cdc4-31 ade6-210 leu1-32 h Our stock
YDM227 lys1-131, mei1-102 P. Nurse
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(YDM189) was transformed with a genomic library and three
plasmids were identi¢ed that were capable of rescuing the
cold-sensitive growth defect. Molecular cloning and sequence
analysis demonstrated that these plasmids contained the actin
gene, act1. act1 has been shown previously to be tightly
linked to the his3 locus [11]. All four suppressor mutations
were found to be extremely tightly linked to his3 and a sub-
sequent sequence analysis of the act1 gene from the four mu-
tants revealed that the same amino acid was altered in all four
cases. The allele of act1 de¢ned by this mutation was desig-
nated act1-48.
3.2. Identi¢cation of other actin alleles
Several other actin mutants were isolated as part of a screen
for cold-sensitive mutants defective in cytokinesis (see Section
2). We used a strategy which enriched for mutants that dip-
loidize by one of the following routes: re-replication of chro-
mosomal DNA, improper chromosome segregation or failure
to undergo cytokinesis followed by nuclear fusion [16^19].
Colonies were visually screened for those which displayed
morphologies characteristic of cytokinesis mutants such as
elongated or branched cells that were often undergoing cell
lysis. Colonies were further screened by staining with DAPI
and calco£uor, which stain DNA and septal material, respec-
tively, to identify those strains with multiple nuclei and either
irregular septa or no septa at all. Five such strains were iden-
ti¢ed (act1-16, act1-32, act1-41, act1-67 and act1-127) and
found to be in the same linkage group. These mutants were
also found to be tightly linked to his3 and in the same linkage
group as act1-48. Furthermore, sequence analysis identi¢ed
mutations in the act1 locus of each of these strains con¢rming
that these strains were actin mutants. The act1-16 and act1-41
as well as the act-32 and act1-127 strains harbored identical
mutations and thus, only one of each was characterized fur-
ther (see below). The cold-sensitive growth defect of act1-16
and act1-67 mutants was determined to be recessive, whereas
the act1-32 cold-sensitive growth defect was found to be dom-
inant. All four actin alleles were compared to wild-type for
growth at 30‡C and 19‡C. The act1-67, act1-48 and act1-32
alleles grew similarly to wild-type at 30‡C, but were unable to
form colonies at 19‡C. The act1-16 mutant strain grew at
30‡C but the cells had aberrant morphologies. At 19‡C, it
grew very poorly although it was capable of forming very
small colonies.
3.3. Genetic analysis
As a way to gain insight into the molecular basis by which
the act1-48 mutation suppressed cdc4-8, we characterized the
act1-48 mutation using further genetic analysis. One mecha-
nism of suppression could be that the act1-48 mutation has a
positive e¡ect on medial ring formation in general. To test this
possibility, we crossed act1-48 to other mutants defective in
medial ring formation such as cdc3-124 (pro¢lin) (KGY492)
[22], cdc8-110 (tropomyosin) (KGY901) [23] and cdc12-112
(KGY1003) [24]. We found that the cdc12-112 and act1-48
mutations were synthetically lethal and both the cdc3-124
act1-48 and cdc8-110 act1-48 double mutants had more severe
growth defects than either single mutant. Thus, it did not
seem that the act1-48 mutation generally promoted the proc-
ess of actin ring formation. A second possibility was that the
act1-48 mutation enhanced the function of Cdc4p or actually
weakly bypasses the requirement for Cdc4p. If this were the
case, one would predict that the act1-48 mutation might res-
cue other alleles cdc4. However, act1-48 was not able to rescue
the cdc4-31 mutant strain (YDM28) even though this muta-
tion is not as severe as the cdc4-8 mutation. Finally, it could
be imagined that any weakly inactivating mutation in the
actin gene would rescue the cdc4-8 mutation. To test this
possibility, we crossed act1-16, act1-32 and act1-67 to cdc4-8
to check if they were capable of rescuing it. This analysis
showed that the cdc4-8 mutation displayed synthetic lethality
in combination with either the act1-16 or act1-32 mutation.
Although some cdc4-8 act1-67 double mutants were recov-
ered, the act1-67 mutation was not able to suppress the
cdc4-8 growth defect at 36‡C. Together, these analyses suggest
that the act1-48 mutation speci¢cally suppresses the defect in
cdc4-8 cells, although the mechanism of this suppression re-
mains unclear.
3.4. Phenotypic characterization of mutants
Actin plays a central role in the formation of the division
septum during cytokinesis. To examine the ability of the actin
mutants to form septa at the restrictive temperature, cells were
grown at 30‡C and then shifted to 19‡C for 6 h and stained
with calco£uor which stains the septa and cell wall. The act1-
16 mutant cells were branched and formed multiple irregular
septa at both 19‡C and 30‡C (Fig. 1B and data not shown).
The act1-32, act1-48 and act1-67 mutant cells formed septa
similar to wild-type at 30‡C (data not shown). However, at
19‡C, act1-67 cells made irregular septa (Fig. 1E) and act1-32
cells had only faint deposits of septal material (Fig. 1C). In-
terestingly, the act1-48 mutant made relatively normal septa
at 19‡C but displayed irregular deposits of septal material at
the ends of the cell (Fig. 1D).
Septal defects are usually indicative of defects in forming
the medial actomyosin ring since the medial ring guides the
placement of the septum [7,9]. Actin patches also play a role
in septum formation as well as polarized growth [25]. To
examine the e¡ects of these actin mutations on actin patches
Fig. 1. Septum staining in the di¡erent actin mutants. Wild-type
(strain YDM105, A), act1-16 (strain YDM181, B), act1-32 (strain
YDM184, C), act1-48 (strain YDM189, D) or act1-67 (strain
YDM182, E) cells growing exponentially at 30‡C were shifted to
19‡C for 6 h, then ¢xed and stained with calco£uor to visualize sep-
tal material.
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and actin rings, the actin mutant strains were pre-cultivated as
described above and then stained with antibodies against actin
and the actin ring component Cdc4p. Cells were also stained
with rhodamine-conjugated phalloidin which gave a similar
staining pattern to that observed using actin antibodies
(data not shown). The act1-67 and act1-16 mutant strains
displayed actin patch staining similar to wild-type cells, but
both strains seemed to make disorganized medial rings as
judged by both actin and Cdc4p staining (Figs. 2 and 3).
These strains also accumulated cells with multiple nuclei due
to a failure in cytokinesis. Occasionally, normal looking me-
dial rings were observed in the act1-16 mutant which is con-
sistent with this strain being able to grow, albeit poorly, at
19‡C (Fig. 3, see arrow). The act1-32 mutant cells displayed
even more drastic defects in cytokinesis as seen by the accu-
mulation of binucleate cells. Actin rings were never observed
in act1-32 mutant cells although actin patches did seem to
localize to the medial region of the cell (Fig. 2). In addition,
the actin patch staining was fainter than that observed in
wild-type (Fig. 2 and data not shown). act1-32 mutant cells
Fig. 3. Cdc4p staining in actin mutant cells. Wild-type (strain YDM105), act1-16 (strain YDM181), act1-67 (strain YDM182), act1-32 (strain
YDM184) or act1-48 (strain YDM189) cells growing exponentially at 30‡C were shifted to 19‡C for 6 h, then ¢xed and double-stained for
Cdc4p and DNA. Arrows indicate structures described in the text.
Fig. 2. Actin staining in actin mutant cells. Wild-type (strain YDM105), act1-16 (strain YDM181), act1-67 (strain YDM182), act1-32 (strain
YDM184) or act1-48 (strain YDM189) cells growing exponentially at 30‡C were shifted to 19‡C for 6 h, then ¢xed and double-stained for actin
and DNA.
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contained short cables as well as punctate structures that con-
tained Cdc4p in the medial region, but no clear Cdc4p rings
(Fig. 3). The act1-48 mutant displayed quite a distinct pheno-
type. Intense medial ring staining was observed in this mutant
using antibodies against both actin (Fig. 2) and Cdc4p (Fig.
3). However, virtually no actin patches were seen in these
cells. Actin patch staining was also faint in act1-48 mutant
cells at the permissive temperature of 30‡C (data not shown).
3.5. Sequence of the mutants
To identify the mutations in the di¡erent actin alleles, the
act1 locus was ampli¢ed from each strain using PCR and the
PCR products were sequenced directly. Each strain was found
to contain a single mutation that resulted in an amino acid
change (Table 2). The act1-16 and act1-41 as well as the act1-
32 and act1-127 pairs of alleles were found to contain identi-
cal mutations. The act1-48 (Gly-46 to Ser), act1-16 (Arg-116
to His), and act1-32 (Gly-245 to Asp) mutations are all in
highly conserved residues. According to the model for the
actin ¢lament, the act1-32 mutation lies in a region of the
actin molecule proposed to be involved in actin/actin interac-
tion and the act1-48 and act1-16 mutations are adjacent to
regions of actin/actin contact [26]. The act1-67 mutation is in
the ATP binding pocket and, therefore, may be interfering
with some aspects of nucleotide binding or hydrolysis.
4. Discussion
We have described, in this paper, the identi¢cation and
characterization of four novel mutations of the S. pombe actin
gene. All four are cold-sensitive mutations but each one has
di¡erent properties. Not surprisingly, the three actin mutants
isolated in the screen for mutants defective in cytokinesis
(act1-16, act1-32 and act1-67) all seem to be defective primar-
ily in the formation of the medial actin ring. Hence, they
arrest as primarily as binucleate cells with absent or abnormal
septa. The act1-16 and act1-67 mutants continue to elongate
and maintain actin patch staining at the restrictive temper-
ature. In contrast, the act1-32 mutant shows a reduced actin
patch staining after prolonged incubation at the restrictive
temperature and does not elongate to the same extent as the
other two alleles, suggesting that the actin patch function may
also be compromised to some extent in this mutant.
Interestingly, the fourth mutation, act1-48, which was iso-
lated as a cdc4-8 suppressing mutation, is not defective in
actin ring formation, but does seem to be defective in the actin
patch formation or stability. Two possible explanations could
account for this di¡erential defect in the actin patch structure
among the mutants. First, the act1-48 mutant protein could
be defective in interacting with a component of patches that is
not required for ring formation. Alternatively, there may be
some intrinsic di¡erence in actin dynamics between actin
patches and the actin ring which renders actin patches more
sensitive to the e¡ects of the act1-48 mutation. Consistent
with its ability to a¡ect actin patch dynamics, we have pre-
viously shown that the act1-48 mutation was synthetically
lethal in combination with mutations in the actin patch pro-
teins Arp3p [25] and Sop2p [27]. However, we have now
found that the act1-48 mutation also displayed negative ge-
netic interactions with mutations in genes required for actin
ring formation, namely cdc12, cdc8 and cdc3-124. Thus, the
possibility remains that this mutant may have generalized de-
fects in the actin function.
An intriguing result is the speci¢city by which the act1-48
mutation suppresses the cdc4-8 mutation. As mentioned
above, the act1-48 mutation will not suppress mutations in
other genes required for actin ring formation or even a di¡er-
ent allele of cdc4. Also, the other actin mutations identi¢ed
here will not suppress cdc4-8. The sequence of the act1-48
mutation has not provided insight into why this mutation
behaves so di¡erently than the others. The mutation is adja-
cent to a region involved in actin/actin interaction and could
thus potentially a¡ect the actin ¢lament formation or stability.
Clearly, more biochemical analysis of the act1-48 mutant pro-
tein will be required to understand its properties.
The sequence of the act1-32 mutation was somewhat more
informative. The same mutation present in the act1-32 allele
was identi¢ed previously in the human actin gene from the
transformed cell line HUT 14 [28]. When this mutant actin
gene was overexpressed in an immortalized but not tumori-
genic cell line, it caused the cells to become tumorigenic [29].
Expression of this corresponding mutant actin gene in Droso-
phila melanogaster £ight muscles causes myo¢brillar disrup-
tion [30]. Since non-mutant actin was present in both of these
experiments, the G245D mutant actin must have been func-
tioning in a dominant manner. Consistent with this interpre-
tation, we found that the cold-sensitive phenotype of the act1-
32 mutation, unlike the other actin mutations identi¢ed here,
was dominant. Because we identi¢ed the act1-32 mutation
based on its ability to induce an increase in the cell ploidy
by causing a failure in the cytokinesis, it would be interesting
to determine if expression of this mutant actin a¡ects the
cytokinesis in mammalian cells and as a result, their ploidy.
Polyploidy is often associated with oncogenic transformation
and thus, the association between expression of this mutant
actin and a transition to a tumorigenic state observed by
Leavitt and colleagues could be due to e¡ects on cytokinesis.
Although the actin cytoskeleton in S. pombe has become the
subject of intensive study in recent years (for review see Gould
and Simanis [9]), until now, only one other actin mutation has
been described in S. pombe [11]. The previously identi¢ed
actin mutant, termed cps8, contained actin patches but formed
disorganized rings and failed in cytokinesis. This phenotype is
much like that of the act1-16, act1-32 and act1-67 mutants
identi¢ed here, although the cytokinesis defect in the act1-32
mutant appears to be tighter and cps8 is not iso-allelic with
the four mutations reported here [11]. Studies of the S. pombe
actin cytoskeleton have been hampered by the lack of reagents
and mutations that completely eliminate speci¢c actin struc-
tures. This problem has been eliminated to some extent
through the use of the drug latrunculin A which will com-
pletely eliminate both actin patches and actin rings in S.
pombe [31]. However, latrunculin A is very expensive and
has the drawback for certain experiments that it eliminates
all actin structures and thus cannot be used to test the e¡ects
Table 2
Identi¢cation of act1 alleles
Mutant allele 48 16/41* 67 32/127*
Wild-type sequence GGT CGT ACC GGT
Gly-46 Arg-116 Thr-160 Gly-245
Mutant sequence AGT CAT ATC GAT
Ser-46 His-116 Ile-160 Asp-245
*These pairs of alleles proved to be iso-allelic to one another.
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of eliminating just actin patches or actin rings. The identi¢ca-
tion of the new actin alleles described here should be helpful
in this regard since the act1-32 and act1-48 alleles most
strongly e¡ect the actin ring and actin patches, respectively.
These new actin alleles should also be useful in genetic screens
designed to identify other F-actin ring or F-actin patch com-
ponents in S. pombe.
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